Bibliografia UJ CM

1/9
Henry G. Bone, Rachel B. Wagman, Maria L. Brandi, Jacques P. Brown, Roland Chapurlat, Steven R. Cummings ., Edward Czerwiński, Astrid Fahrleitner-Pammer, David L. Kendler, Kurt Lippuner, Jean-Yves Reginster, Christian Roux, Jorge Malouf, Michelle N. Bradley, Nadia S. Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W. Dempster, Socrates Papapoulos.
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Lancet. Diabetes & Endocrinology
2017 : Vol. 5, nr 7, s. 513-523
Autor korespondencyjny: Henry G. Bone.
p-ISSN: 2213-8587
AZ
ORG
AIF
IF: 19.313
Adres url:
Streszczenie w PubMed:
DOI:
2/9
Bente L. Langdahl, Christence Stubbe Teglbjarg, Pei-Ran Ho, Roland Chapurlat, Edward Czerwinski, David L. Kendler, Jean-Yves Reginster, Alan Kivitz, E. Michael Lewiecki, Paul D. Miller, Michael A. Bolognese, Michael R. McClung, Henry G. Bone, Osten Ljunggren, Bo Abrahamsen, Ugis Gruntmanis, Yu-Ching Yang, Rachel B. Wagman, Faisal Mirza, Suresh Siddhanti, Eric Orwoll.
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
Journal of Clinical Endocrinology and Metabolism
2015 : Vol. 100, nr 4, s. 1335-1342, il., bibliogr. 10 poz., abstr.
p-ISSN: 0021-972X
AZ
ORG
AIF
IF: 5.531
Streszczenie w PubMed:
3/9
Bente L. Langdahl, Christence S. Teglbjaerg, Pei-Ran Ho, Roland Chapurlat, Edward Czerwinski, David L. Kendler, Jean-Yves Reginster, Alan Kivitz, E. Michael Lewiecki, Paul D. Miller, Michael A. Bolognese, Michael R. McClung, Henry G. Bone, Osten Ljunggren, Bo Abrahamsen, Ugis Gruntmanis, Yu-Ching Yang, Rachel B. Wagman, Suresh Siddhanti, Eric Orwoll.
Denosumab for the Treatment of Men with Low Bone Mineral Density: 24-Month Results from the Adamo Trial.
W: ICE/ENDO 2014, Chicago, June 21-24, 2014
: abstr. OR22-2
SZZ
AWZ
Adres url:
4/9
E. Michael Lewiecki, Socrates Papapoulos, Kurt Lippuner, Christian Roux, Celia J.F. Lin, David L. Kendler, Maria L. Brandi, Edward Czerwinski, Edward Franek, Peter Lakatos, Salvatore Minisola, Jean-Yves Reginster, Soren Jensen, Nadia Daizadeh, Andrea Wang, Mary Gavin, Rachel B. Wagman, Henry G. Bone.
Effect of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Eight-Year Results from the Freedom Extension, Phase 3 Clinical Trial.
W: ICE/ENDO 2014, Chicago, June 21-24, 2014
: abstr. OR22
SZZ
AWZ
Adres url:
5/9
Henry G. Bone, Roland Chapurlat, Maria-Luisa Brandi, Jacques P. Brown, Edward Czerwinski, Marc-Antoine Krieg, Zulema Man, Dan Mellstrom, Sebastiao C. Radominski, Jean-Yves Reginster, Heinrich Resch, Jose A. Roman Ivorra, Christian Roux, Eric Vittinghoff, Nadia S. Daizadeh, Andrea Wang, Michelle N. Bradley, Nathalie Franchimont, Michelle L. Geller, Rachel B. Wagman, Steven R. Cummings, Socrates Papapoulos.
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.
Journal of Clinical Endocrinology and Metabolism
2013 : Vol. 98, nr 11, s. 4483-4492, il., bibliogr. 18 poz.
p-ISSN: 0021-972X
AZ
ORG
AIF
IF: 6.310
6/9
Eric Orwoll, Christence S. Teglbjaerg, Bente L. Langdahl, Roland Chapurlat, Edward Czerwinski, David L. Kendler, Jean-Yves Reginster, Alan Kivitz, E. Michael Lewiecki, Paul D. Miller, Michael A. Bolognese, Michael R. McClung, Henry G. Bone, Osten Ljunggren, Bo Abrahamsen, Ugis Gruntmanis, Yu-Ching Yang, Rachel B. Wagman, Suresh Siddhanti, Andreas Grauer, Jesse W. Hall, Steven Boonen.
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.
Journal of Clinical Endocrinology and Metabolism
2012 : Vol. 97, nr 9, s. 3161-3169, il., bibliogr. 32 poz.
p-ISSN: 0021-972X
AZ
ORG
AIF
IF: 6.430
7/9
Socrates Papapoulos, Roland Chapurlat, Cesar Libanati, Maria Luisa Brandi, Jacques P. Brown, Edward Czerwiński, Marc-Antoine Krieg, Zulema Man, Dan Mellstrom, Sebastiao C. Radominski, Jean-Yves Reginster, Heinrich Resch, Jose A. Roman Ivorra, Christian Roux, Eric Vittinghoff, Matthew Austin, Nadia Daizadeh, Michelle N. Bradley, Andreas Grauer, Steven R. Cummings, Henry G. Bone.
Five years of denosumab exposure in women with postmenopausal osteoporosis : results from the first two years of the FREEDOM extension.
Journal of Bone and Mineral Research
2012 : Vol. 27, nr 3, s. 694-701, il., bibliogr. 14 poz., abstr.
p-ISSN: 0884-0431
AZ
ORG
AIF
IF: 6.128
8/9
David M. Reid, Jean-Pierre Devogelaer, Kenneth Saag, Christian Roux, Chak-Sing Lau, Jean-Yves Reginster, Philemon Papanastasiou, Alberto Ferreira, Florian Hartl, Taiwo Fashola, Peter Mesenbrink, Philip N. Sambrook, HORIZON investigators.
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
2009 : Vol. 373, nr 9671, s. 1253-1263, il., bibliogr. 33 poz.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 30.758
9/9
John A. Eisman, Roberto Civitelli, Silvano Adami, Edward Czerwinski, Chris Recknor, Richard Prince, Jean-Yves Reginster, Mone Zaidi, Dieter Felsenberg, Claire Hughes, Nicole Mairon, Daiva Masanauskaite, David M. Reid, Pierre D. Delmas, Robert R. Recker.
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis : 2-year results from the DIVA study.
Journal of Rheumatology
2008 : Vol. 35, nr 3, s. 488-496, il., bibliogr. 6 poz.
AZ
ORG
AIF
IF: 3.282
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ